Li Han

Li Han

Auto-generated profile, based on publicly available information

Li Han

Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science. China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JCJie Chai
Jie Chai
LHLi Han
Li Han
JZJianbo Zhang
Jianbo Zhang
DHDali Han
Dali Han
LZLei Zou
Lei Zou
HGHongliang Guo
Hongliang Guo
In the era of precision medicine, establishing a patient-derived cell model is crucial, whether in vitro or in vivo. Compared to the traditional cell lines, patient-derived primary cells represent precise genetic features from specific patients, but poor proliferative activity of human primary cells restricts their popular application. Conditional reprogramming (CR) is a new cell culture technique to achieve rapid growth of patient-derived cells in vitro, making it possible to identify the individual difference and screen drugs sensitivity. In this review, we will summarize the application and limitation of CR in tumor and inflammatory-related diseases, indicating the prospect of this technique for preclinical research.